Clinical Trial Design and Artificial Intelligence | Pepgra.com
Clinical trials take up the second half of the ten – 15 year, 1.5 – 2.0 billion USD, cycle of development only for introducing a replacement drug within a market. Therefore, any Clinical Trials Services that end in failure tends to translate not just in losses in terms of investment for the clinical trial but also takes into its ambit the prices incurred as preclinical development costs. This renders the loss for each failed clinical test at 800 million to 1.5 billion USD(Harrer et al., 2019). Keeping these factors in mind, it might be beneficial to explore how AI or AI because it is popularly known are often effectively utilized to re-mould the key phases of a Clinical Trail design with a view to reinforce the speed of success within the trial. Factors causing Failures in Clinical Trials and how AI can help The main two factors that cause failure within clinical trials services pertains to the choice of patient cohorts and therefore the mechanisms used for recrui...